Related Experiment Video
Updated: Sep 21, 2026

Antibiotic Dereplication Using the Antibiotic Resistance Platform
Published on: October 17, 2019
Plasmid-mediated high-level resistance to aminoglycosides in Enterobacteriaceae due to 16S rRNA methylation
Marc Galimand1, Patrice Courvalin, Thierry Lambert
1Unité des Agents Antibactériens, Institut Pasteur, 75724 Paris Cedex 15, France. galimand@pasteur.fr
Abstract:
A self-transferable plasmid of ca. 80 kb, pIP1204, conferred multiple-antibiotic resistance to Klebsiella pneumoniae BM4536, which was isolated from a urinary tract infection. Resistance to beta-lactams was due to the bla(TEM1) and bla(CTX-M) genes, resistance to trimethroprim was due to the dhfrXII gene, resistance to sulfonamides was due to the sul1 gene, resistance to streptomycin-spectinomycin was due to the ant3"9 gene, and resistance to nearly all remaining aminoglycosides was due to the aac3-II gene and a new gene designated armA (aminoglycoside resistance methylase). The cloning of armA into a plasmid in Escherichia coli conferred to the new host high-level resistance to 4,6-disubstituted deoxystreptamines and fortimicin. The deduced sequence of ArmA displayed from 37 to 47% similarity to those of 16S rRNA m(7)G methyltransferases from various actinomycetes, which confer resistance to aminoglycoside-producing strains. However, the low guanine-plus-cytosine content of armA (30%) does not favor an actinomycete origin for the gene. It therefore appears that posttranscriptional modification of 16S rRNA can confer high-level broad-range resistance to aminoglycosides in gram-negative human pathogens.
Insights
A novel gene, armA, found on a plasmid in Klebsiella pneumoniae, confers high-level resistance to multiple aminoglycoside antibiotics. This discovery highlights a new mechanism for antibiotic resistance in gram-negative pathogens.
Area of Science:
- Microbiology
- Molecular Biology
- Genetics
Background:
- The emergence of antibiotic resistance in bacterial pathogens poses a significant global health threat.
- Klebsiella pneumoniae is a common cause of hospital-acquired infections, often exhibiting multidrug resistance.
Purpose of the Study:
- To identify and characterize the genetic basis of multidrug resistance in a clinical isolate of Klebsiella pneumoniae.
- To investigate the function and origin of a novel aminoglycoside resistance gene.
Main Methods:
- Plasmid isolation and characterization (pIP1204, ~80 kb).
- Gene identification for resistance to beta-lactams, trimethoprim, sulfonamides, streptomycin-spectinomycin, and aminoglycosides.
- Cloning of the novel gene 'armA' into Escherichia coli to assess its function.
- Sequence analysis of the armA gene and comparison with known resistance genes.
Main Results:
- The plasmid pIP1204 conferred resistance to multiple antibiotics, including beta-lactams, trimethoprim, sulfonamides, streptomycin-spectinomycin, and various aminoglycosides.
- A newly identified gene, armA, was responsible for high-level resistance to specific aminoglycosides and fortimicin when expressed in E. coli.
- Sequence analysis revealed ArmA shares similarity with 16S rRNA methyltransferases but its low GC content suggests a non-actinomycete origin.
Conclusions:
- The novel armA gene confers significant, broad-range aminoglycoside resistance in gram-negative bacteria.
- Posttranscriptional modification of 16S rRNA is a viable mechanism for high-level aminoglycoside resistance.
- Understanding these resistance mechanisms is crucial for developing strategies against multidrug-resistant pathogens.
Related Concept Videos
Mechanism of Antibiotic Resistance in MRSA
Inhibitors of Bacterial Protein Synthesis
Development of Antibiotic Resistance
Antibiotic Selection
Plasmids
Stringent Response in E. coli

